Core Viewpoint - A class action securities lawsuit has been filed against Reckitt Benckiser Group plc, alleging securities fraud that negatively impacted investors between January 13, 2021, and July 28, 2024 [1][2]. Group 1: Lawsuit Details - The lawsuit claims that Reckitt Benckiser Group plc made false statements regarding the safety of its cow's milk-based formula, Enfamil, which allegedly increased the risk of NEC in preterm infants [2]. - It is alleged that the company concealed the impact of these risks on its sales and exposure to legal claims, leading to materially false and misleading positive statements about its business and operations [2]. Group 2: Next Steps for Investors - Investors who suffered losses during the specified timeframe have until August 4, 2025, to request appointment as lead plaintiff, although participation in any recovery does not require this role [3]. - Class members may be entitled to compensation without any out-of-pocket costs or fees, with no obligation to participate [3]. Group 3: Firm Background - Levi & Korsinsky, LLP has a strong track record in securities litigation, having secured hundreds of millions of dollars for shareholders over the past 20 years [4]. - The firm has been recognized as one of the top securities litigation firms in the United States for seven consecutive years [4].
Reckitt Benckiser Group plc Sued for Securities Law Violations - Contact Levi & Korsinsky Before August 4, 2025 to Discuss Your Rights – RBGLY